Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-504-3 | CAS number: 121-89-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:L
D50 was considered to be 3250 mg/kg bw when Carworth Wistar male rat were treated with 3'-Nitroacetophenone orally by gavage.
Acute dermal toxicity:
LD50 was considered to be 3756 mg/kg bw when rabbits were treated with 3'-Nitroacetophenone by dermal application.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from U.S Environmental protection Agency report
- Qualifier:
- according to guideline
- Guideline:
- other: as below
- Principles of method if other than guideline:
- Acute oral toxicity of 3'-Nitroacetophenone in rats
- GLP compliance:
- not specified
- Test type:
- other: No data
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 3'-Nitroacetophenone
- Molecular formula (if other than submission substance): C8H7NO3
- Molecular weight (if other than submission substance): 165 g/mole
- Substance type: Organic - Species:
- rat
- Strain:
- other: Carworth Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Weight at study initiation: 90 -120g
Fasting period before study: No fasting - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- VEHICLE
Concentration in vehicle: 3250 mg/kg
Amount of vehicle (if gavage): 1 ml to 10 ml
CLASS METHOD (if applicable)
Rationale for the selection of the starting dose:
Doses were given in a logarithmic series differing by a factor of 2. - Doses:
- 3250 mg/kg bw
- No. of animals per sex per dose:
- 5 male
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Statistics:
- The most probable LD50 value and its fiducial range are estimated by the method of Thompson, using the Tables of Weil. The figures in parentheses show limits of ± 1.96 standard deviations while the absence of parentheses indicates that no range is calculable because no dosage resulted in fractional mortality
- Preliminary study:
- No data available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 3 250 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50 % mortality observed.
- Mortality:
- 50 % mortality was observed in treated rats at 3250 mg/kg bw after 14 days
- Clinical signs:
- other: No data available
- Gross pathology:
- No data available
- Other findings:
- No data available
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- LD50 was considered to be 3250 mg/kg bw when Carworth Wistar male rat were treated with 3'-Nitroacetophenone orally by gavage
- Executive summary:
In a Acute oral toxicity study, 5 Carworth Wistar male rats were treated with 3'-Nitroacetophenone in the concentration of 3250 mg/kg bw orally by gavage and observed for 14 days. 50 % mortality was observed in treated rats at 3250 mg/kg bw after 14 days. Therefore, LD50 was considered to be 3250 mg/kg bw when Carworth Wistar male rat were treated with 3'-Nitroacetophenone orally by gavage.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 250 mg/kg bw
- Quality of whole database:
- Data is Limisch 4 and from German Federal Ministry for the Environment and U.S Environmental protection Agency
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from U.S Environmental protection Agency report
- Qualifier:
- according to guideline
- Guideline:
- other: as below
- Principles of method if other than guideline:
- Acute dermal toxicity of 3'-Nitroacetophenone in rabbits
- GLP compliance:
- not specified
- Test type:
- other: No data
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 3'-Nitroacetophenone
- Molecular formula (if other than submission substance): C8H7NO3
- Molecular weight (if other than submission substance): 165 g/mole
- Substance type: Organic - Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data available
- Type of coverage:
- other: Dermal application
- Vehicle:
- not specified
- Details on dermal exposure:
- No data available
- Duration of exposure:
- No data available
- Doses:
- 3756 mg/kg bw
- No. of animals per sex per dose:
- No data available
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Statistics:
- No data available
- Preliminary study:
- No data available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 3 756 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50 % mortality observed.
- Mortality:
- 50 % mortality was observed in treated rabbits at 3756 mg/kg bw after 14 days
- Clinical signs:
- other: No data available
- Gross pathology:
- No data available
- Other findings:
- No data available
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- LD50 was considered to be 3756 mg/kg bw when rabbits were treated with 3'-Nitroacetophenone by dermal application.
- Executive summary:
In a Acute dermal toxicity study, rabbits were treated with 3'-Nitroacetophenone in the concentration of 3756 mg/kg bw by dermal application. 50 % mortality was observed in treated rabbits at 3756 mg/kg bw after 14 days. Therefore,LD50 was considered to be3756 mg/kg bw when rabbits were treated with 3'-Nitroacetophenone by dermal application.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 756 mg/kg bw
- Quality of whole database:
- Data is Limisch 4 and from German Federal Ministry for the Environment and U.S Environmental protection Agency
Additional information
Acute oral toxicity:
In different studies, Pentene3'-Nitroacetophenone has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments and estimated data in rodents, i.e. most commonly in rats for 3'-Nitroacetophenone along with the study available on structurally similar read across substance 3-Nitrobenzoyl chloride (CAS no121-90-4) and Benzylacetone (CAS no 2550-26-7). The predicted data using the OECD QSAR toolbox has also been compared with the experimental data.
In a study given by German Federal Ministry for the Environment (2016) and U.S Environmental protection Agency (1976), acute oral toxicity was evaluated in Carworth Wistar male rats by using 3'-Nitroacetophenone in the concentration of 3250 mg/kg bw orally by gavage and observed for 14 days. 50 % mortality was observed in treated rats at 3250 mg/kg bw after 14 days. Therefore, LD50 was considered to be 3250 mg/kg bw when Carworth Wistar male rat were treated with 3'-Nitroacetophenone orally by gavage.
In another prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute oral toxicity was estimated for 3'-Nitroacetophenone. The LD50 was estimated to be 2734 mg/kg bw when rats were orally exposed with 3'-Nitroacetophenone.
Also it is further supported experimental data conducted by Smythet al(American Industrial Hygiene Association Journal, 30:5, 470-476, 1969) on structurally similar read across substance 3-Nitrobenzoyl chloride (CAS no121-90-4), rats were treated with 3-Nitrobenzoyl chloride orally in the concentration of 2499 mg/kg bw orally. 50 % mortality was observed in treated rats at 2499 mg/kg bw. Therefore, LD50 was considered to be 2499 mg/kg bw (1818.6-3444) when rat were treated with 3-Nitrobenzoyl chloride orally.
This is further supported by experimental data conductedby Moreno et al(Food and Chemical Toxicology, Volume 21, Issue 5, October 1983, Pages 647-649) on another structurally similar read across substance Benzylacetone (CAS no 2550-26-7), rats were treated with Benzylacetone orally in the concentration of 3200 mg/kg bw orally. 50 % mortality was observed in treated rats at 3200 mg/kg bw. Therefore, LD50 was considered to be 3200 mg/kg bw (2300-4450) when rat were treated with Benzylacetone orally.
Thus based on the above studies and predictions on 3'-Nitroacetophenone and its read across substances and by considering weight of evidence , it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus comparing this value with the criteria of CLP regulation, 3'-Nitroacetophenone can be ‘Not classified” for acute oral toxicity.
Acute dermal toxicity:
In different studies, Pentene3'-Nitroacetophenone has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments and estimated data in rodents, i.e. most commonly in rabbits for 3'-Nitroacetophenone along with the study available on structurally similar read across substance Benzylacetone (CAS no 2550-26-7). The predicted data using the OECD QSAR toolbox has also been compared with the experimental data.
In a study given U.S Environmental protection Agency (1976), acute dermal toxicity was evaluated in rabbits by using 3'-Nitroacetophenone in the concentration of 3756 mg/kg bw by dermal application. 50 % mortality was observed in treated rabbits at 3756 mg/kg bw after 14 days. Therefore, LD50 was considered to be 3756 mg/kg bw when rabbits were treated with 3'-Nitroacetophenone by dermal application.
In another prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute dermal toxicity was estimated for 3'-Nitroacetophenone. The LD50 was estimated to be 3825mg/kg bw when rabbits were dermally exposed with 3'-Nitroacetophenone.
Also it is further supported experimental data conducted bMoreno et al(Food and Chemical Toxicology, Volume 21, Issue 5, October 1983, Pages 647-649) on structurally similar read across substance Benzylacetone (CAS no 2550-26-7), rabbits were treated with Benzylacetone in the concentration of 5000 mg/kg bw by dermal application. No mortality was observed in treated rabbits at 5000 mg/kg bw. Therefore, LD50 was considered to be 5000 mg/kg bw when rabbits were treated with Benzylacetone by dermal application.
Thus based on the above studies and predictions on 3'-Nitroacetophenone and its read across substances and by considering weight of evidence , it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus comparing this value with the criteria of CLP regulation, 3'-Nitroacetophenone can be ‘Not classified” for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies and predictions on 3'-Nitroacetophenone and its read across substances and by considering weight of evidence , it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus comparing this value with the criteria of CLP regulation, 3'-Nitroacetophenone can be ‘Not classified” for acute oral and dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.